Founded in 1904, the Fédération Internationale de Football Association (FIFA) is the umbrella organisation of its members, currently 211 national football associations. Its main objectives, enshrined in its statutes, are to develop football around the world, to stage international competitions and to protect the integrity of football (against match manipulation, doping etc.). FIFA is composed of a number of political bodies (such as the FIFA Congress and the FIFA Council) and the administration. The highest political position is the FIFA President, elected every four years by FIFAs member associations. The FIFA administration, with more than 800 people from over 60 nations, is based in Zurich. It is run by the Secretary General (CEO). FIFA stages FIFA World Cups™ in various forms such as youth, mens and womens, futsal, beach soccer or club competitions. The mens FIFA World Cup™ is not only the most popular single sporting event in the world but also the financial backbone for FIFA and its efforts to develop football worldwide. The financial success of the FIFA World Cup™ allows FIFA to run a wide range of football development programmes and to provide funds, infrastructure and know-how to its member associations through the FIFA Forward Development Programme. For more information visit our website.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Carrington Fox is a boutique executive search firm founded in 2001, based in New York City. The company specializes in human capital solutions for global financial markets, focusing on executive and contingent search mandates. With a team of approximately 25 to 50 employees, Carrington Fox generates an estimated annual revenue between $5 million and $25 million. The firm serves clients in investment banking, private equity, hedge funds, tax, accounting, and quantitative analytics. They emphasize long-term partnerships, aiming to understand client needs and candidate aspirations deeply. Carrington Fox is known for its niche expertise in front-office financial roles and quantitative disciplines, providing tailored recruitment processes with a commitment to confidentiality and efficiency.
In todays environment, it has never been easier to feel left behind. Clearoute is a consulting agency with expertise in helping businesses to develop and implement customized solutions that are tailored to their specific needs and goals. You need a strategic ally who can harness brand, performance-marketing, tech & innovation, sales, and finance to deliver significant results and exponential growth. See the future. We transform your complex business challenges into simple profitable solutions.
San Diego FC is a Major League Soccer (MLS) expansion team set to begin play in 2025. Owned by Sir Mohamed Mansour through his family office, Man Capital, the club focuses on social impact, environmental sustainability, and youth development. It operates under the Right to Dream model, a globally recognized soccer academy system that emphasizes holistic athlete development and community engagement. The team will compete in MLS, with home games at Snapdragon Stadium. San Diego FC also features the Right to Dream Academy, which provides free education, housing, and soccer training to young athletes. This academy aims to foster athletic development, academic excellence, and personal growth, mirroring existing facilities in Ghana, Egypt, and Denmark. Additionally, the club engages in community programs that promote diversity and inclusion, targeting local residents and youth athletes from underserved communities. The ownership structure reflects a partnership between Mansour’s Man Capital and the Sycuan Tribe, blending global sports investment with local heritage.